The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Reporting owner

Gibson Christopher

Reporting owner CIK 0001856369 · Chief Executive Officer · Director

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Gibson ChristopherGibson ChristopherGibson Christopher · December 19, 2025 · Conversion · Class A Common StockGibson Christopher · December 4, 2025 · Conversion · Class A Common StockGibson Christopher · November 19, 2025 · Conversion · Class A Common StockGibson Christopher · November 4, 2025 · Conversion · Class A Common StockGibson Christopher · October 23, 2025 · Conversion · Class A Common StockOct 23, 2025Dec 19, 2025
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

5 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 19, 2025RECURSION PHARMACEUTICALS, INC.Class A Common StockGibson ChristopherConversion
Dec 4, 2025RECURSION PHARMACEUTICALS, INC.Class A Common StockGibson ChristopherConversion
Nov 19, 2025RECURSION PHARMACEUTICALS, INC.Class A Common StockGibson ChristopherConversion
Nov 4, 2025RECURSION PHARMACEUTICALS, INC.Class A Common StockGibson ChristopherConversion
Oct 23, 2025RECURSION PHARMACEUTICALS, INC.Class A Common StockGibson ChristopherConversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: RECURSION PHARMACEUTICALS, INC.RXRX · company listings
Gibson ChristopherChief Executive Officer · Director
ConversionClass A Common StockNon-derivative security · Code C40,0000Value: 0Currency not specifiedView ↗
Trade: RECURSION PHARMACEUTICALS, INC.RXRX · company listings
Gibson ChristopherChief Executive Officer · Director
ConversionClass A Common StockNon-derivative security · Code C60,0000Value: 0Currency not specifiedView ↗
Trade: RECURSION PHARMACEUTICALS, INC.RXRX · company listings
Gibson ChristopherChief Executive Officer · Director
ConversionClass A Common StockNon-derivative security · Code C40,0000Value: 0Currency not specifiedView ↗
Trade: RECURSION PHARMACEUTICALS, INC.RXRX · company listings
Gibson ChristopherChief Executive Officer · Director
ConversionClass A Common StockNon-derivative security · Code C60,0000Value: 0Currency not specifiedView ↗
Trade: RECURSION PHARMACEUTICALS, INC.RXRX · company listings
Gibson ChristopherChief Executive Officer · Director
ConversionClass A Common StockNon-derivative security · Code C100,0000Value: 0Currency not specifiedView ↗